Analytical Data
-
Gene name
UNQ846
- Application
-
Alternative Names
TMEM207; UNQ846/PRO1784; Transmembrane Protein 207
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6UWW9
-
Expression Region
1-146 aa
-
AA Sequence
MSRSRLFSVTSAISTIGILCLPLFQLVLSDLPCEEDEMCVNYNDQHPNGWYIWILLLLVLVAALLCGAVVLCLQCWLRRPRIDSHRRTMAVFAVGDLDSIYGTEAAVSPTVGIHLQTQTPDLYPVPAPCFGPLGSPPPYEEIVKTT
-
Molecular Weight
42.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UNQ846 is a recombinant protein that has garnered attention in various fields of biomedical research due to its potential therapeutic applications. This protein is derived from a specific gene sequence that encodes for a protein of interest, which plays a role in critical biological processes. The study of UNQ846 is particularly significant as it could provide insights into mechanisms underlying diseases or cellular functions. With the advent of advanced recombinant DNA technology, scientists can produce large quantities of UNQ846, enabling detailed characterization and evaluation of its biological properties. Furthermore, the potential of this protein in drug development and therapeutic interventions makes it a focal point for researchers aiming to develop novel treatments for conditions such as cancer and autoimmune diseases. By investigating the structure and function of UNQ846, researchers hope to uncover its interactions with other cellular molecules, which could lead to the identification of new biomarkers or drug targets. The ongoing research on UNQ846 emphasizes the importance of recombinant proteins in understanding complex biological systems and advancing medical science.
